Hospital News
Return to Stomach Cancer Overview
More on Stomach Cancer
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody Effective in Previously Untreated Non-Hodgkin's Lymphoma
- Dr. Timothy Wang Named Chief of Gastroenterology at NewYork-Presbyterian/Columbia and Silberberg Professor of Medicine at Columbia University College of Physicians and Surgeons
- Integrative Therapies Program for Children with Cancer at Morgan Stanley Children's Hospital of NewYork-Presbyterian Receives Gift Commitment from Origins Natural Resources
- New Comprehensive Gastrointestinal Health Center To Be Established at NewYork-Presbyterian Weill Cornell
- NewYork-Presbyterian Hospital's Weill Cornell Medical Center Announces Preliminary Lung Cancer Data Involving Patients Treated With Arthritis Medication
- Scientists Identify Cells Necessary for Tumor Angiogenesis
- Two Novel Biologics Studied for Multiple Myeloma
- Weill Cornell Researchers Announce New Gene Therapy Strategy To Promote Hair Growth
Health Library
Clinical Services
Return to Stomach Cancer Overview
More on Stomach Cancer
- Advanced Diagnostics
- Bladder Cancer
- Blood Cancer
- Brain Cancer
- Center for Holistic Urology
- Center for Lymphoma and Myeloma
- Colon Cancer
- Early Lung Cancer Action Program
- Edward S. Harkness Eye Institute
- Esophageal Cancer
- Eye Cancer
- Gastroenterology and Hepatology (Digestive Diseases)
- Gastrointestinal Cancer
- Groundbreaking Therapeutics
- Gynecological Cancer
- Head and Neck Cancer
- Kidney Cancer
- Leukemia and Myeloproliferative Disease Center
- Liver Cancer
- Lung Cancer
- Mesothelioma
- Minimal Access Surgery Center
- Oncology (Cancer)
- Pancreatic and Biliary Cancer
- Pediatric Cancer
- Prevention Programs
- Prostate Cancer
- Rectal Cancer
- Robert M. Ellsworth Ophthalmic Oncology Center
- Soft Tissue and Bone Cancer
- Spirit of Care Program
- Stomach Disease
- Testicular Cancer
- Urologic Cancer
Stomach Cancer
NewYork-Presbyterian Cancer Centers physicians are addressing cancers of the stomach medically, with chemotherapy approaches; surgically, with emphasis on minimally invasive procedures; and through radiation therapy to spare patients from major surgery. Patients benefit from the collaboration between gastroenterologists, who perform endoscopic ultrasound of the stomach to define the extent of the gastric cancer, and surgical oncologists, who use laparoscopy to stage the disease and then determine the most effective way to remove the tumor. Our surgeons were among the first in the country to use laparoscopic procedures for patients with very early gastric cancer and are increasingly using this approach, which dramatically enhances recovery by shortening length of stay in the hospital and enabling patients to return to normal activities more quickly.
Patients with more advanced digestive disease cancers can be treated with intraoperative chemotherapy following surgery to reduce the tumor. Radiation oncologists provide treatment for gastric cancers that combine chemotherapy with radiation therapy to improve outcomes. In addition, they have pioneered techniques in intraoperative brachytherapy—implanting either temporary or permanent radioactive seeds at the time of surgery for abdominal malignancies.
At the same time, our physicians are pursuing research into tumor biology, as well as the pathogenesis of gastrointestinal inflammation and its relationship to gastrointestinal cancer. They are also studying the physiologic, oncologic, and immunologic consequences of abdominal surgery.
Patients who come to NewYork-Presbyterian Cancer Centers for care also have access to some of the most important and advanced clinical trials in the country for gastric cancer. These trials include investigations related to:
- Agents to enhance blood build-up in patients who are preoperative with GI malignancies
- Intraperitoneal chemotherapy for advanced GI malignancies
Hospital News
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody Effective in Previously Untreated Non-Hodgkin's Lymphoma More
Health Library
Clinical Services
RELATED LINKS
- Radiation Oncology, NewYork-Presbyterian/Columbia
- Radiation Oncology, NewYork-Presbyterian/Weill Cornell
- Digestive & Liver Diseases, NewYork-Presbyterian/Columbia
- Gastroenterology and Hepatology, NewYork-Presbyterian/Weill Cornell
- Hematology/Oncology, NewYork-Presbyterian/Columbia
- Hematology and Medical Oncology, NewYork-Presbyterian/Weill Cornell
- Herbert Irving Comprehensive Cancer Center
- Weill Cornell Comprehensive Cancer Care and Blood Disorders
